)
Pay in 4 interest-free payments of $5.13 Learn more
Ships within 48 hours · Estimated delivery Aug 22 - Aug 27
Individual results vary, and NexLife does not guarantee weight loss, treatment success, clinical outcomes, prescription approval, medication eligibility, pharmacy availability, fulfillment timelines, or delivery outcomes
This means it stays active in the body for a much longer period, allowing for once-daily dosing compared to the more frequent dosing required for native IGF-1
GLP-1 agonists are generally safe and well-tolerated, but ongoing monitoring ensures any issues are identified and managed promptly, optimising both your diabetes control and cardiovascular health
The FDA does not review these supplements for safety or efficacy before they hit the market
Mounjaro is primarily a diabetes medication meant for type 2 diabetes management, whereas Zepbound is approved for weight management in adults with obesity or those with obesity-related health conditions
